Mediolanum farmaceutici SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mediolanum farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014088
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolic areas. It offers products for neuropsychiatric area, which include anxiety, depression and migraine. Mediolanum provides products for vascular area which include peripheral obliterant arteriopathy and chronic venous insufficiency. The company provides research and development services to discover new drugs. It invests in various patents and projects in several areas such as endocrinology, rheumatoid arthritis, vaccines for prostate and kidney cancer, and others. Mediolanum is headquartered in Milano, Italy.

Mediolanum farmaceutici SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mediolanum Farmaceutici Acquires GX301, Therapeutic Vaccine For Treatment Of Cancer, From Genovax 10
Partnerships 12
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 12
Licensing Agreements 13
Mediolanum Enters into Research & Development Cooperation and Licensing Agreement with Apeptico 13
Asset Transactions 14
Biocodex Acquires Non Opthalmic Arm Of Laboratoire Leurquin Mediolanum 14
Mediolanum farmaceutici SpA – Key Competitors 15
Mediolanum farmaceutici SpA – Key Employees 16
Mediolanum farmaceutici SpA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Key Facts 2
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mediolanum farmaceutici SpA, Deals By Therapy Area, 2011 to YTD 2017 8
Mediolanum farmaceutici SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mediolanum Farmaceutici Acquires GX301, Therapeutic Vaccine For Treatment Of Cancer, From Genovax 10
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 12
Mediolanum Enters into Research & Development Cooperation and Licensing Agreement with Apeptico 13
Biocodex Acquires Non Opthalmic Arm Of Laboratoire Leurquin Mediolanum 14
Mediolanum farmaceutici SpA, Key Competitors 15
Mediolanum farmaceutici SpA, Key Employees 16
Mediolanum farmaceutici SpA, Subsidiaries 17

★海外企業調査レポート[Mediolanum farmaceutici SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務分析
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • International Flavors & Fragrances Inc (IFF):企業の財務・戦略的SWOT分析
    International Flavors & Fragrances Inc (IFF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報
    Summary Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices suc …
  • Ringkjoebing Landbobank A/S:企業の戦略・SWOT・財務情報
    Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report Summary Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ICF International Inc (ICFI):企業の財務・戦略的SWOT分析
    ICF International Inc (ICFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ramsay Health Care Limited:企業の戦略・SWOT・財務情報
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Linklaters Llp:企業の戦略・SWOT・財務分析
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bangkok Insurance Pcl
    Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report Summary Bangkok Insurance Pcl - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Standard Alliance Insurance Plc:企業の戦略・SWOT・財務分析
    Standard Alliance Insurance Plc - Strategy, SWOT and Corporate Finance Report Summary Standard Alliance Insurance Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Atnahs Pharma UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atnahs Pharma UK Ltd (Atnahs Pharma), a subsidiary of Waymade Plc, is a developer, manufacturer, supplier and distributor of pharmaceutical products. The company provides products such as anacal ointment; dermacort cream; dipentum; gygel, a spermicidal contraceptive, and among others. Atnahs …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • G&W Electric Company:企業の戦略的SWOT分析
    G&W Electric Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • JSC IC Allianz:企業の戦略・SWOT・財務分析
    JSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary JSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • HSS Engineers Berhad (HSSEB):企業の財務・戦略的SWOT分析
    HSS Engineers Berhad (HSSEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PT Jakarta International Hotels & Development Tbk:企業の戦略・SWOT・財務情報
    PT Jakarta International Hotels & Development Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jakarta International Hotels & Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Transocean Ltd.:企業の戦略・SWOT・財務分析
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Phoenix Global Resources Plc (PGR):石油・ガス:M&Aディール及び事業提携情報
    Summary Phoenix Global Resources Plc (Phoenix), formerly known as Andes Energia Plc, is an upstream oil and gas company. It conducts exploration, development and production of oil and gas for conventional and unconventional resources. It has diversified portfolio of oil and gas assets in Argentina. …
  • Sellier & Bellot J.S.C.:企業の戦略・SWOT・財務分析
    Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆